Small caps

In an exclusive interview with Benzinga, Evoke Pharma (NASDAQ: EVOK) CEO Dave Gonyer discussed the company’s opportunities. Evoke is currently focused on its drug EVK-001. EVK-001 is a nasal spray to treat diabetic gastroparesis. Gonyer began by discussing the drug's potential market....

In an interview with Benzinga, Zix (NASDAQ: ZIXI) Chairman and CEO Rick Spurr discussed the company’s email encryption business. Zix has three primary offerings: A data loss prevention product to protect content that is trying to be maliciously distributed or stolen, a bring your own device...

Single Family Home (SFH) REITs are still relatively new, with the first appearing on the scene in late 2012. For those investors not familiar with these securities, they are publicly traded companies with a business model of purchasing single family homes (hopefully at a discount to fair value),...

Mandalay Digital (NASDAQ: MNDL) builds platforms for wireless carriers to monetize digital content. Solutions range from content management to billing. In an exclusive interview with Benzinga, CEO Peter Adderton discussed several of the company’s businesses. Prior to his career at Mandalay...

In the ETF world, investing in small-cap stocks has become almost synonymous with the iShares Russell 2000 ETF (NYSE: IWM). It is the benchmark du jour for companies with market capitalizations of less than $2 billion and is the most widely traded of its peers on a daily basis. Since debuting...

Libbey (NYSE: LBY) on Thursday morning announced first quarter sales of $181.6 million versus $183.5 million for the same quarter last year and EBITDA was $20.1 million versus $26.2 million year over year. In an exclusive interview with Benzinga, Ken Boerger explained why investors look at...

The morning of Tuesday, April 29, wasn't much different than other recent morning. Not for the marijuana sector, unfortunately. Many issues were slipping, many of those for a third consecutive session. The morning of Tuesday, April 15, was worse. And not just for the marijuana sector, which...

Amid the growing discussion of a correction, investors are naturally looking for stocks that will hold up well. Two important considerations to factor, in a decision to buy, are seeking out those publicly traded companies that have increasing revenues and that are in defensive sectors. United-...

“We believe we have 58 percent market share in U.S. foodservice, which means that in six out of every ten restaurants you eat in you are drinking out of one of our products,” said Ken Boerger, vice president and treasurer of Libbey Inc. (NYSE: LBY). In an exclusive interview with Benzinga,...

Last week brought carnage for stocks. The S&P 500 was down about 2.5 percent, but some individual stocks were hit much harder. These four each lost nearly 40 percent of value: Imperva (NYSE: IMPV)- Down 43 Percent Imperva is a $733 million company that develops, markets and sells services...

Terra Tech (OTC: TRTC), and its subsidiary GrowOp, were started with the intention to develop and manufacture growth tools for in-home cannabis cultivation for medical marijuana users, but has quickly grown into big-time player in the hydroponic growth space. Terra Tech is currently only...

U.S. stocks kicked off a new month and new quarter with solid gains as U.S. manufacturing growth improved in March. The indexes have now logged a three-day winning streak, an accomplishment which was completely absent throughout all of March. The S&P 500 hit new all-time highs of 1,885.84...

For small cap investing, the presence of a celebrity owner, spokesperson or other affiliation can often times be a very bullish factor for a stock. It cannot be underestimated what Michael Jordan did for Nike (NYSE: NKE). Nike's rival, Under Armour (NYSE: UA), has also benefitted greatly from...